All articles

2026

1. Why Retatrutide Listings Show Stability Data, Not Expiration Date August 26
2. Why Some Retatrutide Listings Use the Abbreviation Reta Instead August 26
3. Why Some Retatrutide Listings Reference an IUPAC Name August 24
4. How Retatrutide Listings Describe Cold Chain vs Ambient Shipping August 24
5. Retatrutide Listings Mention a Counterion or Buffer Composition August 23
6. Why Some Retatrutide Listings Include a Synonym List August 22
7. Purity vs Potency: The Difference on a Retatrutide Listing August 22
8. How Retatrutide's Peptide Backbone Is Described Across Listings August 21
9. Why Retatrutide Listings Say Investigational Compound August 20
10. How the Term "Long-Acting" Describes Retatrutide in Listings August 20
11. Why Retatrutide's Molecular Formula Differs Across Listings August 20
12. Why Some Retatrutide Listings Call It a Peptide vs. Protein August 17
13. How Retatrutide's Amino Acid Sequence Length Compares to Tirzepatide's August 17
14. Retatrutide Molecular Weight vs Tirzepatide Molecular Weight August 16
15. Why Retatrutide Listings Reference the Development Code LY3437943 August 16
16. How Lyophilized Retatrutide Should Be Stored Before Reconstitution August 14
17. How to Compare Two Retatrutide Listings Side by Side August 13
18. What Documentation Should a Retatrutide Listing Include August 13
19. Retatrutide vs Semaglutide vs Tirzepatide Naming Conventions August 11
20. How Retatrutide Listings Describe Purity Percentage August 10